Evofem Biosciences, Inc. (EVFM)
Evofem Biosciences, Inc. operates as a biopharmaceutical enterprise dedicated to innovating and bringing to market treatments that address critical underserved areas in women's sexual and reproductive health. Their leading commercial offering is Phexxi, a vaginal gel specifically designed as a contraceptive. Additionally, the company is actively advancing EVO100, an antimicrobial vaginal gel under development, intended to prevent the urogenital spread of both Chlamydia trachomatis and Neisseria gonorrhoeae infections in women. The company's main office is situated in San Diego, California.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Evofem Biosciences, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 132.53M shares outstanding
USEvofem Biosciences, Inc. operates as a biopharmaceutical enterprise dedicated to innovating and bringing to market treatments that address critical underserved areas in women's sexual and reproductive health. Their leading commercial offering is Phexxi, a vaginal gel specifically designed as a contraceptive.
Additionally, the company is actively advancing EVO100, an antimicrobial vaginal gel under development, intended to prevent the urogenital spread of both Chlamydia trachomatis and Neisseria gonorrhoeae infections in women.
The company's main office is situated in San Diego, California.
Leadership
Ivy Zhang
Chief Financial Officer & Secretary
Saundra Pelletier
Interim Chair, President & Chief Executive Officer
Amy Raskopf
Chief Business Development Officer
Ellen Thomas
Chief of Staff
Employees
32
Country
US
Sector
Healthcare
Website
evofem.com
based on 132.53M shares outstanding
US30d Avg
140.83K
60d Avg
131.92K
90d Avg
190.27K